Natraj Proteins Ltd (NATRAJPR) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Natraj Proteins Ltd on NSE and BSE, with an AI summary of each filing.
We are pleased to submit the Un-Audited Financial Results for the quarter/half-year ended 30th September, 2026 along with Statement of Assets and Liabilities and Cash flow and Limited ....
Financial Result · 30 Oct 2026, 12:47 am
Natraj Proteins Posts Q2 FY27 Net Profit of ₹34.50 Lakh Natraj Proteins reported revenue from operations of ₹1,820.15 lakh for the quarter ended 30th Sep'26, down 32.39% YoY from ₹2,692.17 lakh and 42.07% QoQ from ₹3,142.12 lakh. Net profit stood at ₹34.50 lakh, rebounding YoY from a net loss of ₹164.98 lakh but falling 83.61% QoQ from ₹210.53 lakh. EPS for the quarter was ₹0.92. For the half-year ended 30th Sep'26, revenue stood at ₹4,962.27 lakh with a net profit of ₹245.03 lakh against a net loss of ₹286.46 lakh in the prior-year period.
We are pleased to submit the Un-Audited Financial Results along with Statement of Assets and Liabilities and Cash Flow and Limited Review Report thereon by Statutory Auditors for the Quarter/Half-Year ....
Outcome · 30 Oct 2026, 12:37 am
Natraj Proteins Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 1,820 (-32.4% YoY | -42.1% QoQ) ■ EBITDA: 109 (Loss to Profit YoY | -61.2% QoQ) ■ EBITDA Margin (%): 6.0 (Loss to Profit YoY | -296 bps QoQ) ■ PAT: 34.5 (Loss to Profit YoY | -83.6% QoQ) ■ EPS (INR): 0.92 (Loss to Profit YoY | -83.6% QoQ)
Natraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the following businesses: 1. ....
Intimation · 29 Oct 2026, 5:30 am
Natraj Proteins Schedules Board Meeting for Q2 FY27 Financial Results Natraj Proteins Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and approve the un-audited financial results alongside the Statutory Auditors' Limited Review Report for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed and will reopen 48 hours after the declaration of the financial results to stock exchanges.
The members of the company at their 35th AGM has re-appointed Shri Sharad Kumar Jain as the Whole-time Director for a further period of 3 (Three) years w.e.f. 01/10/2026.
Change in Management · 30 Sept 2026, 2:25 am
We are pleased to inform that members of the Company at their 35th Annual General Meeting held on 29.09.2026 has approved the matters as stated in the Notice of Annual General Meeting. ....
Annual General Meeting · 30 Sept 2026, 2:10 am
We are pleased to submit the declaration of results of Remote E-voting and E-voting for the 35th Annual General Meeting held on 29.09.2026 along with Consolidated Scrutiniser Report.
Annual General Meeting · 30 Sept 2026, 2:03 am
Submission of proceedings of the 35th Annual General Meeting of the Company held on Tuesday, 29th September, 2026, pursuant to Regulation 30(2), read with part A of Schedule III of the ....
Annual General Meeting · 29 Sept 2026, 8:41 pm
Submission of letter dispatched to shareholders who have not registered their email addresses.
Others (Uncategorized) · 09 Sept 2026, 9:41 pm
Natraj Proteins Dispatches FY26 Annual Report Access Letters to Unregistered Shareholders Natraj Proteins Limited has dispatched communication letters pursuant to SEBI LODR Regulation 36(1)(b) to shareholders whose email addresses are unregistered. The communication provides access links to the Annual Report for FY25-26 and the Notice for the 35th Annual General Meeting, scheduled for 29th Sep'26 at 2:00 PM via Video Conferencing/OAVM. Shareholders can access the documents on the company's website, BSE, or CDSL, or request physical copies via email through the Registrar and Share Transfer Agent, Ankit Consultancy Private Limited.
Submission of copy of 35th Annual General Meeting notice of the company to be held on 29th September, 2026 at 2 P.M.
Annual General Meeting · 07 Sept 2026, 8:56 pm
Submission of 35th Annual Report along with notice of Annual General Meeting to be held on Tuesday, 29th September, 2026, at the Registered Office of the Company at 2.00 P.M. through Video ....
Others (Uncategorized) · 07 Sept 2026, 8:39 pm
Pursuant to provisions of Regulation 44 of SEBI (LODR) Regulations, 2015, the Company is proving facility to members of the company to cast their votes through electronic means.
Annual General Meeting · 05 Sept 2026, 12:06 am
Natraj Proteins Announces E-Voting Details for 35th AGM Natraj Proteins Limited will host its 35th Annual General Meeting on 29th Sep'26, providing remote e-voting facilities to members via CDSL. The cut-off date to determine e-voting entitlement is set for 22nd Sep'26. The remote e-voting window opens on 26th Sep'26 at 9:00 AM and closes on 28th Sep'26 at 5:00 PM. CS Ishan Jain has been appointed as the scrutinizer for the voting process.
Re-appointment of Shri Sharad Kumar Jain (DIN: 02757935) as the Whole Time Director of the Company for a further period of 3 years w.e.f. 1st October, 2026 subject to approval of members ....
Change in Management · 13 Aug 2026, 11:05 pm
Appointment of the Cost Auditor of the Company for the Financial Year 2026-27.
Change in Management · 13 Aug 2026, 10:51 pm
Natraj Proteins Appoints New Cost Auditor for FY27 Natraj Proteins Ltd. (BSE: 530119) has appointed M/s Yogesh Chourasia and Associates (Firm Reg. No. 000271) as its Cost Auditor. The appointment, recommended by the Audit Committee and approved by the Board on 13th Aug'26, is for the financial year ending 31st Mar'27. M/s Yogesh Chourasia and Associates is a firm of Cost Accountants with experience in cost accounting, management accounting, and financial analysis. This change is a routine appointment for the upcoming financial year.
We are pleased to submit the Un-audited financial results along with limited review report for the Quarter ended 30th June,2026.
Financial Result · 13 Aug 2026, 10:38 pm
Natraj Proteins Reports Strong Q1 FY27 Profit Turnaround Natraj Proteins reported a significant turnaround for the quarter ended 30th Jun'26, posting a net profit of ₹210.53 lakhs versus a loss of ₹121.48 lakhs YoY. This was driven by a 18.4% YoY rise in revenue from operations to ₹3,142.12 lakhs. QoQ, profit surged 89.9% from ₹110.84 lakhs, while revenue climbed 66.5%. The performance reflects strong operational growth and improved profitability. Basic EPS for the quarter stood at ₹5.62, a sharp recovery from -₹3.24 in the prior year's quarter.
We are pleased to submit the outcome of 03/2026-27 meeting of Board of Directors held on 13th August,2026 as per Regulation 30 of SEBI (LODR) Regulation, 2015 for approval of Un-audited ....
Outcome · 13 Aug 2026, 10:19 pm
Natraj Proteins Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 3,142 (+18.3% YoY | +66.5% QoQ) ■ EBITDA: 281 (Loss to Profit YoY | +63.5% QoQ) ■ EBITDA Margin (%): 8.9 (Loss to Profit YoY | -16 bps QoQ) ■ PAT: 211 (Loss to Profit YoY | +89.9% QoQ) ■ EPS (INR): 5.62 (Loss to Profit YoY | +89.9% QoQ)
Natraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the following businesses: 1. ....
Intimation · 13 Aug 2026, 5:30 am
Natraj Proteins Board Meeting Scheduled for Q1 FY27 Results Natraj Proteins Ltd (BSE: 530119) has scheduled a board meeting for 13th Aug'26 to consider and approve its un-audited financial results for the quarter ended 30th Jun'26. The agenda also includes reviewing the limited review report from the statutory auditors for the same period. In accordance with insider trading regulations, the trading window for the company's securities is currently closed and will reopen 48 hours after the financial results are publicly declared to the stock exchanges.
We are pleased to submit the audited financial result for the quarter/year ended on 31.03.2026 alongwith Statement of Assets and Liabilities and Cash Flow.
Financial Result · 23 May 2026, 1:11 am
Natraj Proteins Swings to Profit in FY26 on Lower Expenses Natraj Proteins reported a full-year profit of ₹113.51 Lakhs for the year ended 31 Mar'26, a significant turnaround from a loss of ₹146.27 Lakhs in FY25. This was achieved despite a 14.3% YoY drop in revenue to ₹10,112.13 Lakhs, driven by lower total expenses. For Q4 FY26, net profit was ₹110.84 Lakhs, down 12.1% YoY. The company reported a basic EPS of ₹3.03 for FY26 compared to ₹(3.90) in the previous year. Total assets grew 29.6% YoY to ₹7,602.53 Lakhs.
we are pleased to submit the Audited Financial Results along with Statement of Assets and Liabilities and Cash Flow and Auditors' Report thereon by Statutory Auditors for the Quarter/Year ....
Outcome · 23 May 2026, 1:06 am
Natraj Proteins Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 1,887 (-18.2% YoY | -34.4% QoQ) ■ EBITDA: 172 (-8.2% YoY | -51.4% QoQ) ■ EBITDA Margin (%): 9.1 (+99 bps YoY | -320 bps QoQ) ■ PAT: 111 (-12.1% YoY | -61.7% QoQ) ■ EPS (INR): 2.96 (-12.2% YoY | -61.7% QoQ)
Natraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve the following businesses along ....
Intimation · 22 May 2026, 5:30 am
Natraj Proteins Board to Approve Q4 & FY26 Results on 22nd May'26 Natraj Proteins Ltd (BSE: 530119) has scheduled its Board of Directors meeting for 22nd May'26. The agenda includes the consideration and approval of the audited financial results for the quarter and financial year ended 31st Mar'26. The Board will also take on record the statutory auditors' report and approve the full audited financial statements for the year. The trading window for company securities is currently closed and will reopen 48 hours after the results are declared to the stock exchanges.
Registrar and Share Transfer agent of the Company M/S Ankit Consultancy Private Limited has dispatched the letter to the holders of physical securities related to mandatorily furnishing ....
Others (Uncategorized) · 09 May 2026, 10:43 pm
Natraj Proteins Mandates KYC Update for Physical Shareholders Natraj Proteins, via its RTA Ankit Consultancy, has issued letters to holders of physical securities mandating the submission of KYC details. This includes PAN, nomination, contact information, bank account details, and specimen signature, as per SEBI circulars. Effective 1st Apr'24, all payments such as dividends or redemptions will only be made electronically. Shareholders must update their details to receive payments and avail services from the RTA. This action aligns with SEBI's push for electronic compliance and transaction security.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 14 Apr 2026, 7:27 pm
Natraj Proteins Confirms It Does Not Qualify as a Large Corporate Natraj Proteins Ltd. confirmed to the BSE on 14th Apr'26 that it does not meet the criteria of a "Large Corporate" under SEBI regulations. This determination is based on its outstanding borrowings of ₹36.02 crore as of 31st Mar'26. Consequently, the company is exempt from the mandatory requirement to file the Annual Disclosure (Annexure B2) for the financial year ended 31st Mar'26, which obligates large corporates to raise a portion of their incremental borrowings via debt securities.
Pursuant to regulation 33 of SEBI(LODR), 2015, we are pleased to submit the financial results for the Quarter/ Nine months ended 31st December, 2025.
Financial Result · 14 Feb 2026, 12:15 am
Natraj Proteins Reports Q3FY26 Profit Amidst 9M Loss Natraj Proteins reported a Q3FY26 standalone profit after tax of ₹289.13 lakhs, a significant turnaround from the ₹164.98 lakh loss in Q2FY26 and a substantial rise from the ₹3.31 lakh profit in Q3FY25. Total income for the quarter stood at ₹2881.33 lakhs, up 6.8% QoQ but down 13.8% YoY. For the nine months ended 31st Dec'25, the company posted a net profit of ₹2.67 lakhs, sharply contracting from a loss of ₹272.38 lakhs in the prior year period. Basic EPS for Q3FY26 was ₹7.72.
1. The Board of Directors Considered and approved the Standalone Un-audited Financial Results of the Company for the quarter/nine months ended 31st December, 2025. 2. The Board of Directors ....
Outcome · 13 Feb 2026, 11:43 pm
Natraj Proteins Limited - Financial Result for the Quarter ended 31st Dec'25 (Standalone, INR Lakhs) ■ Revenue: 2877 (-13.9% YoY | +6.9% QoQ) ■ EBITDA: 354 (+463.7% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 12.3 (+1043 bps YoY | Loss to Profit QoQ) ■ PAT: 289 (+8635.0% YoY | Loss to Profit QoQ) ■ EPS (INR): 7.72 (+8477.8% YoY | Loss to Profit QoQ)
Natraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Natraj Proteins Limited has ....
Intimation · 13 Feb 2026, 5:30 am
Natraj Proteins Board Meeting Set for Feb'26 to Approve Q3 Results Natraj Proteins Ltd. (BSE: 530119) has scheduled a Board of Directors meeting for 13th Feb'26 at 3:00 PM. The primary agenda is to consider and approve the standalone un-audited financial results for the quarter and nine months ended 31st Dec'25. The Board will also review the auditor's limited review report for the same period. The trading window for company securities is currently closed and will reopen 48 hours after the results are declared to the stock exchanges.
We are pleased to submit the Outcome of the Board Meeting held on 13/11/2025 for approval of the unaudited quarterly/half year financial statements for the quarter/half year ended on 30/09/2025 ....
Outcome · 14 Nov 2025, 12:58 am